456 FES PET is an Imaging Biomarker of Pharmacodynamic Response to Estrogen Receptor (ER) Modulating Therapies in Breast Cancer
Krohn, K.A, Linden, H.M, Kurland, B.F, Specht, J.M, Gadi, V.K, Peterson, L.M, Schubert, E.K, Link, J.M, Mankoff, D.A, Eary, J.F
Published in European journal of cancer (1990) (01.11.2012)
Published in European journal of cancer (1990) (01.11.2012)
Get full text
Journal Article
259P Weekly ladiratuzumab vedotin monotherapy for metastatic triple-negative breast cancer
Tsai, M., Han, H.S., Montero, A.J., Tkaczuk, K.H., Assad, H., Pusztai, L., Hurvitz, S.A., Wilks, S.T., Specht, J.M., Nanda, R., Mita, M., O'Shaughnessy, J., Krop, I.E., Medgyesy, D., Abraham, J., Modi, S., Li, H., Wu, S., Garfin, P.M., Burris, H.A.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article